{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:31:04Z","timestamp":1780338664694,"version":"3.54.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/mnh.0b013e328365addf","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T22:32:56Z","timestamp":1380321176000},"page":"599-606","source":"Crossref","is-referenced-by-count":16,"title":["Current issues in the management and monitoring of hypertension in chronic kidney disease"],"prefix":"10.1097","volume":"22","author":[{"given":"Pranav S.","family":"Garimella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210205","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1001\/jama.2010.650","article-title":"US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.","volume":"303","author":"Egan","year":"2010","journal-title":"JAMA"},{"issue":"Suppl 1","key":"R2-3-20210205","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/16.suppl_1.70","article-title":"Prevalence of hypertension in renal disease.","volume":"16","author":"Ridao","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R3-3-20210205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/bmj.321.7258.412","article-title":"Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.","volume":"321","author":"Adler","year":"2000","journal-title":"BMJ"},{"key":"R4-3-20210205","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.HYP.35.2.539","article-title":"Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification.","volume":"35","author":"Ogden","year":"2000","journal-title":"Hypertension"},{"key":"R5-3-20210205","first-page":"337","article-title":"Improving Global Outcomes (KDIGO) Blood Pressure Work GroupKDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease.","volume":"2","author":"Kidney","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R7-3-20210205","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cjca.2013.01.005","article-title":"The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.","volume":"29","author":"Hackam","year":"2013","journal-title":"Can J Cardiol"},{"key":"R9-3-20210205","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1097\/HJH.0b013e32833b49fe","article-title":"Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations.","volume":"28","author":"Fan","year":"2010","journal-title":"J Hypertens"},{"key":"R10-3-20210205","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa022273","article-title":"Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.","volume":"348","author":"Clement","year":"2003","journal-title":"N Engl J Med"},{"key":"R12-3-20210205","doi-asserted-by":"crossref","first-page":"d286","DOI":"10.1136\/bmj.d286","article-title":"Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial.","volume":"342","author":"Myers","year":"2011","journal-title":"BMJ"},{"key":"R14-3-20210205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/07420528.2013.750490","article-title":"H, Ayala D E, Portaluppi F. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.","volume":"30","author":"Hermida","year":"2013","journal-title":"Chronobiol Int"},{"key":"R15-3-20210205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.ajkd.2013.03.025","article-title":"Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: a 5,693-patient cross-sectional analysis from Spain.","volume":"62","author":"Gorostidi","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R16-3-20210205","doi-asserted-by":"crossref","first-page":"e55419","DOI":"10.1371\/journal.pone.0055419","article-title":"Reversed dipper blood-pressure pattern is closely related to severe renal and cardiovascular damage in patients with chronic kidney disease.","volume":"8","author":"Wang","year":"2013","journal-title":"PloS one"},{"key":"R18-3-20210205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/MBP.0b013e32835d126c","article-title":"Linking clinic and home: a randomized, controlled clinical effectiveness trial of real-time, wireless blood pressure monitoring for older patients with kidney disease and hypertension.","volume":"18","author":"Rifkin","year":"2013","journal-title":"Blood Press Monit"},{"key":"R19-3-20210205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.2013.6549","article-title":"Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial.","volume":"310","author":"Margolis","year":"2013","journal-title":"JAMA"},{"key":"R20-3-20210205","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESHESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"R21-3-20210205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"R22-3-20210205","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"R23-3-20210205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with nondiabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"R24-3-20210205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-154-8-201104190-00335","article-title":"Systematic review: blood pressure target in chronic kidney disease and proteinuria as an effect modifier.","volume":"154","author":"Upadhyay","year":"2011","journal-title":"Ann Intern Med"},{"key":"R25-3-20210205","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"R26-3-20210205","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease.","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"key":"R27-3-20210205","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1503\/cmaj.121468","article-title":"Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis.","volume":"185","author":"Lv","year":"2013","journal-title":"CMAJ"},{"key":"R28-3-20210205","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children.","volume":"361","author":"Wuhl","year":"2009","journal-title":"N Engl J Med"},{"key":"R29-3-20210205","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/hr.2010.162","article-title":"Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine.","volume":"33","author":"Hayashi","year":"2010","journal-title":"Hypertens Res"},{"key":"R30-3-20210205","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus.","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"R33-3-20210205","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1681\/ASN.2011040361","article-title":"Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD.","volume":"22","author":"Hermida","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R34-3-20210205","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/dc11-0297","article-title":"Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes.","volume":"34","author":"Hermida","year":"2011","journal-title":"Diabetes Care"},{"key":"R35-3-20210205","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/ndt\/gfr557","article-title":"Effects of chronotherapy on blood pressure control in nondipper patients with refractory hypertension.","volume":"27","author":"Almirall","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R36-3-20210205","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/HYPERTENSIONAHA.112.200477","article-title":"A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.","volume":"61","author":"Rahman","year":"2013","journal-title":"Hypertension"},{"key":"R37-3-20210205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000223772","article-title":"Application of body composition monitoring to peritoneal dialysis patients.","volume":"163","author":"Crepaldi","year":"2009","journal-title":"Contrib Nephrol"},{"issue":"Suppl 4","key":"R38-3-20210205","doi-asserted-by":"crossref","first-page":"iv31","DOI":"10.1093\/ndt\/gfs420","article-title":"Utility of bioimpedance spectroscopy (BIS) in the management of refractory hypertension in patients with chronic kidney disease (CKD).","volume":"27","author":"Verdalles","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R39-3-20210205","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3109\/0886022X.2011.649672","article-title":"Efficacy of aliskiren in Japanese chronic kidney disease patients with hypertension.","volume":"34","author":"Sakai","year":"2012","journal-title":"Ren Fail"},{"key":"R40-3-20210205","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1093\/ndt\/gfq857","article-title":"Aliskiren reduces sympathetic nerve activity and blood pressure in chronic kidney disease patients.","volume":"26","author":"Siddiqi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R41-3-20210205","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/HYPERTENSIONAHA.110.167486","article-title":"Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease.","volume":"57","author":"Dhaun","year":"2011","journal-title":"Hypertension"},{"key":"R42-3-20210205","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1365-2125.2011.04102.x","article-title":"The safety and tolerability of spironolactone in patients with mild to moderate chronic kidney disease.","volume":"73","author":"Edwards","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"R43-3-20210205","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers.","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"key":"R44-3-20210205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1681\/ASN.2011040430","article-title":"Sodium intake, ACE inhibition, and progression to ESRD.","volume":"23","author":"Vegter","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R45-3-20210205","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1681\/ASN.2005111241","article-title":"Increasing body mass index and obesity in the incident ESRD population.","volume":"17","author":"Kramer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R46-3-20210205","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/ajkd.2003.50059","article-title":"Demographics and trends in overweight and obesity in patients at time of kidney transplantation.","volume":"41","author":"Friedman","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R47-3-20210205","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinte.162.16.1867","article-title":"Overweight and obesity as determinants of cardiovascular risk: the Framingham experience.","volume":"162","author":"Wilson","year":"2002","journal-title":"Arch Intern Med"},{"key":"R48-3-20210205","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.ajkd.2005.08.015","article-title":"Association between body mass index and CKD in apparently healthy men.","volume":"46","author":"Gelber","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R49-3-20210205","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","article-title":"Body mass index and the risk of development of end-stage renal disease in a screened cohort.","volume":"65","author":"Iseki","year":"2004","journal-title":"Kidney Int"},{"key":"R50-3-20210205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2009.09.011","article-title":"Nonrandomized trial of weight loss with orlistat, nutrition education, diet, and exercise in obese patients with CKD: 2-year follow-up.","volume":"55","author":"MacLaughlin","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R51-3-20210205","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ajh.2012.80","article-title":"Compliance with a structured weight loss program is associated with reduced systolic blood pressure in obese patients with chronic kidney disease.","volume":"25","author":"MacLaughlin","year":"2012","journal-title":"Am J Hypertens"},{"key":"R52-3-20210205","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/ndt\/gfl684","article-title":"Rapidly progressive renal failure associated with successful pharmacotherapy for obesity.","volume":"22","author":"Courtney","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R53-3-20210205","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/ijo.2012.7","article-title":"Overweight, obesity and intentional weight loss in chronic kidney disease: NHANES 1999-2006.","volume":"36","author":"Navaneethan","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"R54-3-20210205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.ajkd.2008.10.003","article-title":"Obesity management in adults with CKD.","volume":"53","author":"Kramer","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R55-3-20210205","first-page":"145","article-title":"2 diabetes.","volume":"369","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Nephrology & Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNH.0b013e328365addf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:30:05Z","timestamp":1620963005000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041552-201311000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mnh.0b013e328365addf","relation":{},"ISSN":["1062-4821"],"issn-type":[{"value":"1062-4821","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}